Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract with increasing incidence worldwide. Although a deeper understanding of the underlying mechanisms of IBD has led to new therapeutic approaches, treatment options are still limited. Severe adverse events...
Saved in:
Main Authors: | Markus Ries (Author), Brice Moulari (Author), Maryam A. Shetab Boushehri (Author), Mohamed Ehab Ali (Author), Daniel Molnar (Author), Arnaud Béduneau (Author), Yann Pellequer (Author), Alf Lamprecht (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanoparticle-based delivery enhances anti-inflammatory effect of low molecular weight heparin in experimental ulcerative colitis
by: Tawfek Yazeji, et al.
Published: (2017) -
A nanoparticle-based approach to improve the outcome of cancer active immunotherapy with lipopolysaccharides
by: Maryam A. Shetab Boushehri, et al.
Published: (2018) -
Anti-inflammatory effects of acacia and guar gum in 5-amino salicylic acid formulations in experimental colitis
by: Henusha D. Jhundoo, et al.
Published: (2021) -
Anti-Inflammatory Activity of Chitosan and 5-Amino Salicylic Acid Combinations in Experimental Colitis
by: Henusha D. Jhundoo, et al.
Published: (2020) -
Polymeric Nanoparticles' Accumulation in Atopic Dermatitis: Clinical Comparison between Healthy, Non-Lesional, and Lesional Skin
by: Céline Try, et al.
Published: (2023)